Diprivan (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Diprivan drug offered from Fresenius Kabi USA, LLC. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | PROPOFOL |
SUBSTANCE NAME: | PROPOFOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | General Anesthesia [PE],General Anesthetic [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, EMULSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-11-17 |
END MARKETING DATE: | 0000-00-00 |
Diprivan HUMAN PRESCRIPTION DRUG Details:
Item Description | Diprivan from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2009-11-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-269_01c16360-6310-4741-bd9f-c626588c858a |
PRODUCT NDC: | 63323-269 |
APPLICATION NUMBER: | NDA019627 |
Other PROPOFOL Pharmaceutical Manufacturers / Labelers: